Mammography
An X-ray examination of the breast that is the primary method for screening detection of breast cancer at an early, asymptomatic stage — the only imaging test with mortality reduction documented in randomized clinical trials.
Number of studies
2
Safety
Requires caution
Time to effects
Not applicable — mammography is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
An X-ray examination of the breast that is the primary method for screening detection of breast cancer at an early, asymptomatic stage — the only imaging test with mortality reduction documented in randomized clinical trials.
- →The only breast imaging test with mortality reduction from breast cancer proven in randomized clinical trials
- →Detects cancerous changes, including microcalcifications, before they become palpable or produce any symptoms
- →Very low radiation dose relative to the diagnostic value obtained
| Test type | X-ray examination of the breast with tissue compression, in at least two views per breast |
|---|---|
| Level of evidence | Strong — the only breast imaging test with mortality reduction documented in randomized trials |
| Target group | Women in preventive screening programs, usually from age 40–50, and women with breast symptoms |
| Scope of the exam | Both breasts in craniocaudal and oblique views, with optional tomosynthesis (DBT) |
| Radiation dose | Very low, on the order of a fraction of the annual dose from natural background environmental radiation |
| Status | Screening test available through population programs, and a diagnostic test for clinical symptoms |
Understand
Overview
Mammography is an imaging test that uses low-dose X-rays to obtain a detailed image of the internal structure of breast tissue. The breast is gently compressed between two plates of the mammography machine, which flattens the tissue, reduces the radiation dose needed for a readable image, and reduces the overlap of structures that could otherwise obscure subtle findings. Standard practice takes two images of each breast from different angles, letting the radiologist assess the tissue from two views and reducing false-negative results caused by normal tissue overlapping itself.
The clinical value of mammography lies in its ability to detect cancerous changes before they become palpable or produce any symptoms — microcalcifications with a pattern suggestive of malignancy, or small nodules with irregular margins, can be visible on mammography years before they reach a size detectable by physical exam. Mammography is the only breast imaging test for which randomized clinical trials with long-term follow-up have shown a genuine reduction in breast cancer mortality in the screened population, unlike breast ultrasound or MRI, which play mainly a supplementary role or are used in higher-risk groups.
The test is ordered mainly in two distinct contexts. The first, and most important from a public health standpoint, is preventive screening in women without symptoms, performed on a regular cycle from a defined age as part of national screening programs. The second context is diagnostic mammography, ordered for specific symptoms — a palpable lump, a change in breast shape, nipple discharge, or skin changes — or to further investigate an unclear screening mammogram result, usually with additional views or magnification of a specific area.
On the practical side, the test doesn't require special preparation beyond the recommendation to avoid deodorants, talcum powder, or lotions on the breasts and underarms on the day of the exam, since these can mimic microcalcifications on the image. The procedure itself usually takes 10–20 minutes, and the actual moment of exposure and breast compression lasts a few seconds per image. Many women's biggest worry is about pain or discomfort from breast compression — the intensity of sensation is individual and can depend on the phase of the menstrual cycle, so it's worth scheduling the test outside the immediate premenstrual period, when breast tissue tends to be more tender. A written report is usually available within a few days to two weeks.
Several recurring misconceptions surround mammography. Some women believe the test carries significant radiation risk — in reality, the radiation dose in a single mammogram is very low and many times lower than doses considered risky, and the benefits of early breast cancer detection significantly outweigh the theoretical risk from exposure. Another common misconception is treating a normal breast ultrasound result as equivalent to mammography — the two methods image tissue differently and detect partly different types of changes, which is why mammography is recommended as the primary test for women past a certain age, rather than substituting ultrasound for it.
It's also worth understanding breast tissue density, which significantly affects the test's sensitivity — in women with dense glandular tissue (more common in younger women and those before menopause), mammography tends to be less sensitive, because both dense tissue and a cancerous lesion appear as bright areas on the image, making them harder to distinguish. In such cases, the radiologist may recommend a supplementary test, most often breast ultrasound.
Mammography remains the foundational, randomized-trial-proven tool for screening detection of breast cancer, and its regular use at recommended intervals translates into detecting cancers at an earlier, better-prognosis stage and a well-documented reduction in mortality in the screened population. The decision about when to start screening and how often to repeat it is worth discussing individually with your doctor, taking into account your personal risk profile, family history, and the guidelines in effect in your country.
Mechanism of action
The principle behind mammography rests on the difference in X-ray absorption between tissues of different densities. Breast fatty tissue absorbs radiation relatively weakly, glandular and connective tissue more strongly, and calcifications and solid tumors most strongly of all soft-tissue structures — which is why they appear as brighter areas against a darker fatty-tissue background on the final image. The mammography machine uses low-energy X-rays specifically calibrated to contrast soft breast tissue, unlike standard X-ray machines optimized for bone tissue.
The second key factor is mechanical compression of the breast between two plates of the machine. Flattening the tissue has several simultaneous effects — it reduces the thickness of tissue the radiation must penetrate, allowing a lower dose while maintaining good image quality; it separates overlapping glandular structures, reducing the risk that a subtle change is hidden under normal tissue; and it immobilizes the breast, eliminating image blur from movement during exposure.
The third mechanism is taking images from at least two different views for each breast — standard practice is the craniocaudal view and the mediolateral oblique view, which also captures part of the axilla. Assessing the same tissue from two different angles lets the radiologist verify whether a suspicious area seen on one image represents a genuine structural change or merely an effect of normal structures overlapping — a phenomenon known as tissue superimposition.
The fourth, increasingly common mechanism for boosting test sensitivity is digital breast tomosynthesis (DBT), in which the machine takes a series of images from different angles around the breast, and software reconstructs them into a set of thin cross-sectional layers of tissue, analogous to the principle behind CT scanning. Tomosynthesis significantly reduces the effect of tissue overlap characteristic of classic two-dimensional mammography, increasing lesion detection, especially in women with dense glandular tissue, at a comparable or only slightly higher radiation dose.
Differential radiation absorption by tissue
Fatty tissue, glandular tissue, and solid lesions absorb X-rays to different degrees, creating the contrast visible on the image.
Breast compression between the machine's plates
Flattening the tissue reduces the required radiation dose, separates overlapping structures, and eliminates motion blur.
Taking images in two views
Assessing tissue from two different angles lets the radiologist distinguish a genuine change from the effect of normal glandular structures overlapping.
Tomosynthesis reconstructing cross-sectional layers
A series of images taken at different angles enables reconstruction of thin tissue layers, reducing the effect of structural overlap characteristic of classic two-dimensional mammography.
Evidence: strong — based on 2 studies in this database.
Benefits
Common myths
MythMammography carries significant radiation risk.
FactThe radiation dose in a single mammogram is very low, and the documented benefits of early breast cancer detection clearly outweigh the theoretical risk from exposure.
MythA normal breast ultrasound result eliminates the need for mammography.
FactThe two methods image breast tissue differently and detect partly different types of changes — for women in the screening age range, mammography remains the primary test, with ultrasound serving a supplementary role.
MythMammography detects all breast cancers with 100% accuracy.
FactThe test's sensitivity is very high but not 100%, especially in women with dense glandular tissue — which is why breast self-exams and regular clinical checkups remain an important supplement, not a substitute, for mammography.
MythIf there's no breast cancer in the family, screening isn't necessary.
FactThe vast majority of breast cancer cases occur in women without a significant family history, which is why population screening programs target all women in a given age range regardless of family history.
Forms & variants
Mammography comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Digital two-dimensional (2D) mammography
The standard test with two views per breast, forming the basis of most screening programs.
Best for: Routine screening for most women in a population prevention program
Mammography with tomosynthesis (DBT, 3D)
An extension of the test that reconstructs thin cross-sectional tissue layers, reducing the effect of structural overlap.
Best for: Women with dense glandular tissue or an unclear 2D mammography result
Diagnostic mammography with additional views
A test focused on a specific area of interest, with magnification or additional spot compression.
Best for: Investigating an unclear screening mammography result or assessing a palpable lump
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
The test involves brief breast compression, which some women experience as discomfort or mild pain that resolves immediately after each image. The intensity of sensation varies and can depend, among other things, on the phase of the menstrual cycle.
The age to start screening depends on the guidelines in effect in a given country and usually falls between 40 and 50 for average-risk women; women with a family or genetic history start screening earlier.
In population screening programs, the test is usually recommended every 1–2 years, depending on age and local guidelines; more frequent checkups may be recommended for women at elevated risk.
No special preparation is needed — it's only recommended to avoid deodorants, talcum powder, and lotions around the breasts and underarms on the day of the test, since they can mimic changes on the image.
An unclear result usually leads to additional views, magnification of a specific area, or a supplementary test, most often breast ultrasound; in some cases, a biopsy of the suspicious lesion is needed for a definitive assessment.
What to combine with
Good combinations
Pap Smear (Cervical Cytology) — Mammography and cervical cytology are two distinct, complementary screening tests in women's cancer prevention, often recommended on similar schedules
Ultrasound (Sonography) — Breast ultrasound plays a supplementary role to mammography, especially in women with dense glandular tissue or an unclear result
Menopause — The age of menopause and its associated hormonal changes affect breast tissue density and the recommended screening schedule
Safety
Side effects & contraindications
Possible side effects
Transient discomfort or pain from breast compression during imaging, usually resolving immediately after the test
A very low, but non-zero, dose of ionizing radiation with each test
Risk of a false-positive result leading to additional imaging or a biopsy of a lesion that ultimately proves benign
Risk of a missed lesion (false-negative result), especially in women with very dense glandular tissue
Contraindications
Pregnancy — due to X-ray exposure, though very low; the urgency of the test is decided individually with strong clinical suspicion
Very young age without risk factors and without clinical symptoms — in younger women, dense glandular tissue lowers the test's sensitivity, and breast ultrasound is usually preferred
Interactions
Deodorants, talcum powder, perfume, and lotions applied on the day of the test around the breasts and underarms can mimic microcalcifications on the image and should be avoided before the exam
Breast tissue density significantly affects test sensitivity — in women with dense glandular tissue, mammography tends to be less sensitive and may need to be supplemented with breast ultrasound
The phase of the menstrual cycle can affect breast tenderness during compression — it's worth scheduling the test outside the immediate premenstrual period
Breast implants require additional views (the Eklund technique) for a complete assessment of glandular tissue around the implant
A recent breast biopsy or surgery can leave scar tissue or metal clips that need to be accounted for when interpreting the image
Is it worth taking?
Who it's for
- Women within the age range covered by a population screening program, without clinical breast symptoms
- Women with a palpable lump, change in breast shape, nipple discharge, or skin changes requiring workup
- Women with a family history of breast or ovarian cancer requiring earlier initiation of screening
- Women previously treated for breast cancer requiring regular monitoring of remaining glandular tissue
Not for
- Pregnancy — due to X-ray exposure, though very low; the urgency of the test is decided individually with strong clinical suspicion
- Very young age without risk factors and without clinical symptoms — in younger women, dense glandular tissue lowers the test's sensitivity, and breast ultrasound is usually preferred
Evidence
Worth knowing
Mammography is the only breast imaging test for which randomized clinical trials have shown reduced breast cancer mortality in the screened population.
Tomosynthesis (DBT) reconstructs the breast image in thin cross-sectional layers, similar to CT scanning, increasing lesion detection in women with dense glandular tissue.
Breast tissue density significantly affects test sensitivity — dense tissue and a cancerous lesion can appear as similarly bright areas on the image.
Standard practice takes two images of each breast from different views, to distinguish a genuine change from the effect of normal structures overlapping.
Studies
Across all randomized screening trials, mammography was associated with reduced breast cancer mortality in the group invited to screening compared with the control group among women aged 50 and older.
Siu AL, U.S. Preventive Services Task Force, Annals of Internal Medicine, 2016
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
Strong evidenceSiu AL, on behalf of the U.S. Preventive Services Task Force · Annals of Internal Medicine · 2016
A recommendation based on a review of randomized clinical trials, confirming reduced breast cancer mortality from screening mammography in women aged 50 and older.
View studyEffectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis
Moderate evidenceMagnus MC, Ping M, Shen MM, Bourgeois J, Magnus JH · Journal of Women's Health · 2011
A meta-analysis of randomized trials showing a significant reduction in breast cancer mortality from screening mammography also in the younger 39–49 age group.
View studySources & bibliography
The PubMed identifiers in this knowledge base were checked against NCBI records (October 2026). If you spot an error in a source, please let us know via the contact form.
Compare with similar entries
About the authors of this entry
Author
Redakcja VitMode — Serce i układ krążeniaEditorial team
VitMode Editorial — Heart and Circulation is the VitMode editorial team responsible for: the heart, blood pressure, lipids and cardiovascular prevention. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
75 publications on this site
Editorial review
Redakcja VitMode — Badania i biomarkeryEditorial team
VitMode Editorial — Lab Tests and Biomarkers is the VitMode editorial team responsible for: laboratory tests, interpreting results and ageing biomarkers. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
272 publications on this site
Related entries

Pap Smear (Cervical Cytology)
A microscopic examination of cells collected from the cervix that can detect precancerous changes years before cancer could develop — one of the most effective screening tests in oncology, responsible for a dramatic drop in cervical cancer mortality wherever it's performed systematically.

Ultrasound (Sonography)
Ultrasound uses high-frequency sound waves, not radiation, to image organs in real time — it's safe, widely available, and inexpensive, though image quality depends heavily on the operator's experience and the patient's anatomy.

Menopause
The permanent cessation of menstruation caused by the ovaries ceasing function — a turning point involving significant metabolic, cardiovascular, and bone changes that calls for deliberate prevention.

DEXA scan
The gold standard for measuring bone mineral density and one of the most accurate ways to assess body composition — more precise than popular bioimpedance scales.

Colonoscopy
An endoscopic examination of the entire large intestine that lets doctors find and immediately remove polyps before they can turn into cancer — the only widely available screening test that combines diagnosis and treatment in a single procedure.

VO2 max
The maximum amount of oxygen the body can take up during exercise — one of the strongest, well-documented predictors of lifespan, measurable in a sports diagnostics lab.

MRI (Magnetic Resonance Imaging)
MRI uses a strong magnetic field and radio waves, not ionizing radiation, to produce images with exceptionally high soft-tissue contrast — brain, spinal cord, joints, and internal organs — at the cost of a much longer scan time than CT.

Echocardiography (Cardiac Echo)
Echocardiography is a real-time ultrasound test of the heart that — unlike an ECG, which only assesses electrical activity — shows chamber structure, valve function, and the strength of the heart muscle's contraction, with no radiation exposure.
Related articles
PoradnikiFibrocystic Breast Changes: Causes and Management
Tenderness, lumpiness, and a "grainy" feeling in the breasts just before a period affects up to 90% of women at some point in their lives — a phenomenon common enough that medicine long ago stopped calling it a disease. Fibrocystic breast changes (today more often called simply fibrocystic changes rather than "fibrocystic breast disease") don't themselves raise breast-cancer risk, but they can be a source of real discomfort and anxiety, especially when a new, palpable lump appears. We explain the hormonal mechanism behind these changes, what actually helps ease symptoms versus what's a myth, and when a breast lump needs urgent evaluation.
September 16, 2026
PoradnikiHormone Replacement Therapy in Menopause: Who Should Consider It, When, and What's the Real Risk?
The 2002 WHI study triggered a global panic around hormone replacement therapy, and prescriptions dropped by half almost overnight. Two decades of further analysis have painted a much more nuanced picture — one that depends above all on age and timing of initiation. We explain what the data actually show, who has a favorable risk-benefit balance today, and who should exercise particular caution.
August 22, 2026
